Who Supplies Irbesartan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Irbesartan exports, with 123+ registered manufacturers shipping to buyers across 68+ countries — yet a handful of companies dominate the shipments. MACLEODS PHARMACEUTICALS LTD holds the largest share at 30.4% (export value: $32.3M). Close behind, CAPLIN POINT LABORATORIES LIMITED (11.3%, $12.0M). MYLAN LABORATORIES LIMITED (8.4%, $8.9M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Irbesartan? Top Manufacturers & Their Buyers
Flow of Irbesartan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Irbesartan Supplier Network — Key Market Intelligence
The Irbesartan export market from India is led by MACLEODS PHARMACEUTICALS LTD, which alone commands a 30.4% share, shipping $32.3M worth of product across 178 shipments. The second-largest exporter, CAPLIN POINT LABORATORIES LIMITED, contributes $12.0M (11.3%) to the overall market. Combined, the top two suppliers alone account for 41.7% of all Irbesartan exports, indicating a relatively concentrated supply base.
Across all 123 tracked manufacturers, the total Irbesartan export value stands at $106.3M from 2.7K shipments. The market average shipment value is $39.8K. The single largest buyer relationship in terms of trade value is MACLEODS PHARMA USA INC, receiving $19.8M worth of product.
The combined buyer network spans 18 named purchasing companies, including MACLEODS PHARMA USA INC, SYNERRY SDN BHD, JAMP PHARMA CORPORAT, NEOETHICALS, S.A,, NUEVOS ETICOS NEOETHICALS, S.A. and 13 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the first-largest Irbesartan exporter from India, with a market share of 30.4% and a total export value of $32.3M across 178 shipments. Their average shipment value of $181.3K is above the market average of $39.8K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MACLEODS PHARMA USA INC is the dominant customer, accounting for 61.3% of this supplier's tracked business. Top customers include:
• MACLEODS PHARMA USA INC — $19.8M across 109 shipments (61.3% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $10.7M across 59 shipments (33.2% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $856.9K across 5 shipments (2.7% of this supplier's total exports)
• SYNERRY SDN BHD — $457.3K across 3 shipments (1.4% of this supplier's total exports)
• JAMP PHARMA CORPORAT — $442.6K across 2 shipments (1.4% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $181.3K is 355% above the market average of $39.8K, consistent with large-order contracts or value-added formulations.
2CAPLIN POINT LABORATORIES LIMITED
CAPLIN POINT LABORATORIES LIMITED is the second-largest Irbesartan exporter from India, with a market share of 11.3% and a total export value of $12.0M across 106 shipments. Their average shipment value of $113.5K is above the market average of $39.8K, suggesting premium or bulk contract pricing.
CAPLIN POINT LABORATORIES LIMITED serves 5 named buyers in our database. NEOETHICALS, S.A, is the dominant customer, accounting for 56.4% of this supplier's tracked business. Top customers include:
• NEOETHICALS, S.A, — $6.8M across 60 shipments (56.4% of this supplier's total exports)
• NUEVOS ETICOS NEOETHICALS, S.A. — $3.8M across 33 shipments (31.5% of this supplier's total exports)
• FARMA SOLUTION SOCIE — $649.8K across 6 shipments (5.4% of this supplier's total exports)
• NUEVOS ETICOS NEOETHICALS, S.A. — $468.3K across 4 shipments (3.9% of this supplier's total exports)
• NEOETHICALS, S.A, — $338.2K across 3 shipments (2.8% of this supplier's total exports)
Key Insight: CAPLIN POINT LABORATORIES LIMITED's per-shipment value of $113.5K is 185% above the market average of $39.8K, consistent with large-order contracts or value-added formulations.
3MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the third-largest Irbesartan exporter from India, with a market share of 8.4% and a total export value of $8.9M across 217 shipments. Their average shipment value of $41.2K is above the market average of $39.8K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. CSP VIATRIS SANTE AT CSP- LAB is the dominant customer, accounting for 64.8% of this supplier's tracked business. Top customers include:
• CSP VIATRIS SANTE AT CSP- LAB — $5.8M across 141 shipments (64.8% of this supplier's total exports)
• XXLANXXRELXXD LXXITEX — $1.1M across 27 shipments (12.3% of this supplier's total exports)
• CSP VIATRIS SANTE AT CSP- LAB — $773.8K across 19 shipments (8.6% of this supplier's total exports)
• CSP MYLAN SAS AT CSP LABO 274 — $717.9K across 17 shipments (8.0% of this supplier's total exports)
• CSP VIATRIS SANTE AT CSP- LAB — $555.5K across 13 shipments (6.2% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $41.2K is 4% above the market average of $39.8K, consistent with large-order contracts or value-added formulations.
4SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Irbesartan exporter from India, with a market share of 5.1% and a total export value of $5.4M across 298 shipments. Their average shipment value of $18.2K is below the market average of $39.8K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $2.4M across 132 shipments (44.3% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $2.1M across 116 shipments (38.9% of this supplier's total exports)
• SUN PHARMA ANZ PTY L — $375.3K across 21 shipments (6.9% of this supplier's total exports)
• TO THE ORDER — $286.0K across 16 shipments (5.3% of this supplier's total exports)
• ALPHAPHARM PTY LIMIT — $253.8K across 14 shipments (4.7% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (298 shipments) at a per-shipment value of $18.2K, indicating a broad distribution network with many smaller, regular orders.
5ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Irbesartan exporter from India, with a market share of 4.1% and a total export value of $4.4M across 189 shipments. Their average shipment value of $23.2K is below the market average of $39.8K, reflecting a high-volume, competitive pricing strategy.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. APOTEX PTY LTD. is the dominant customer, accounting for 63.4% of this supplier's tracked business. Top customers include:
• APOTEX PTY LTD. — $2.8M across 120 shipments (63.4% of this supplier's total exports)
• APOTEX PTY LTD. — $829.6K across 36 shipments (18.9% of this supplier's total exports)
• J. KNIPPER & COMPANY — $366.6K across 16 shipments (8.4% of this supplier's total exports)
• ARROW PHARMACEUTICAL — $237.2K across 10 shipments (5.4% of this supplier's total exports)
• APOTEX PTY LIMITED — $172.4K across 7 shipments (3.9% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (189 shipments) at a per-shipment value of $23.2K, indicating a broad distribution network with many smaller, regular orders.
6MACLEODS PHARMACEUTICALS LIMITED
MACLEODS PHARMACEUTICALS LIMITED is the fifth-largest Irbesartan exporter from India, with a market share of 3.3% and a total export value of $3.5M across 89 shipments. Their average shipment value of $39.2K is below the market average of $39.8K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. MACLEODS PHARMA USA INC is the dominant customer, accounting for 78.1% of this supplier's tracked business. Top customers include:
• MACLEODS PHARMA USA INC — $2.7M across 70 shipments (78.1% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $496.7K across 13 shipments (14.2% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $124.3K across 3 shipments (3.6% of this supplier's total exports)
• ASCEND — $92.1K across 2 shipments (2.6% of this supplier's total exports)
• SYNOPTIS INDUSTRIAL — $51.3K across 1 shipments (1.5% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (89 shipments) at a per-shipment value of $39.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Irbesartan Flows
Once Irbesartan leaves the manufacturing plants of companies like MACLEODS PHARMACEUTICALS LTD and CAPLIN POINT LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $106.3M. United States absorbs the largest share at 37.2% ($39.5M), followed by France (15.4%) and Australia (7.9%).
In United States — the top destination — named importers include MACLEODS PHARMA USA,INC, MACLEODS PHARMA USA,INC,, MACLEODS PHARMA USA INC. In France, key buyers are CSP VIATRIS SANTE AT CSP- LAB,, CSP MYLAN SAS AT CSP- LABO 274,, ARROW GENERIQUES,.
This geographic spread reflects Irbesartan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Irbesartan Go? Top Importing Countries & Their Buyers
Trade flow of Irbesartan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Irbesartan imports from India, with a total trade value of $39.5M across 150 shipments — representing a 37.2% share of all Irbesartan exports. The average shipment value of $263.7K is above the global average of $39.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Irbesartan importers in United States: MACLEODS PHARMA USA,INC is the largest buyer, accounting for 50.0% ($19.8M) of this market's total imports.
• MACLEODS PHARMA USA,INC — $19.8M (50.0% of United States's total)
• MACLEODS PHARMA USA,INC, — $12.3M (31.1% of United States's total)
• MACLEODS PHARMA USA INC — $3.7M (9.3% of United States's total)
Key Insight: United States's per-shipment average of $263.7K (562% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Irbesartan imports from India.
2France
France ranks as the second-largest destination for Irbesartan imports from India, with a total trade value of $16.4M across 182 shipments — representing a 15.4% share of all Irbesartan exports. The average shipment value of $90.2K is above the global average of $39.8K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Irbesartan importers in France: CSP VIATRIS SANTE AT CSP- LAB, is the largest buyer, accounting for 35.3% ($5.8M) of this market's total imports.
• CSP VIATRIS SANTE AT CSP- LAB, — $5.8M (35.3% of France's total)
• CSP MYLAN SAS AT CSP- LABO 274, — $2.0M (12.3% of France's total)
• ARROW GENERIQUES, — $2.0M (12.1% of France's total)
Key Insight: France's per-shipment average of $90.2K (126% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Irbesartan imports from India.
3Australia
Australia ranks as the third-largest destination for Irbesartan imports from India, with a total trade value of $8.4M across 106 shipments — representing a 7.9% share of all Irbesartan exports. The average shipment value of $79.2K is above the global average of $39.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Irbesartan importers in Australia: APOTEX PTY LTD. is the largest buyer, accounting for 37.1% ($3.1M) of this market's total imports.
• APOTEX PTY LTD. — $3.1M (37.1% of Australia's total)
• APOTEX PTY. LTD. — $1.1M (13.0% of Australia's total)
• APOTEX PTY LTD — $1.1M (12.7% of Australia's total)
Key Insight: Australia's per-shipment average of $79.2K (99% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Irbesartan imports from India.
4Nicaragua
Nicaragua ranks as the fourth-largest destination for Irbesartan imports from India, with a total trade value of $7.6M across 12 shipments — representing a 7.2% share of all Irbesartan exports. The average shipment value of $636.5K is above the global average of $39.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Irbesartan importers in Nicaragua: NEOETHICALS, S.A, is the largest buyer, accounting for 90.1% ($6.9M) of this market's total imports.
• NEOETHICALS, S.A, — $6.9M (90.1% of Nicaragua's total)
Key Insight: Nicaragua's per-shipment average of $636.5K (1498% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nicaragua is a key market for Irbesartan imports from India.
5Belgium
Belgium ranks as the fifth-largest destination for Irbesartan imports from India, with a total trade value of $5.4M across 144 shipments — representing a 5.1% share of all Irbesartan exports. The average shipment value of $37.6K is below the global average of $39.8K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Irbesartan importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 48.0% ($2.6M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $2.6M (48.0% of Belgium's total)
Key Insight: Belgium receives frequent, smaller shipments of Irbesartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Belgium is a key market for Irbesartan imports from India.
People Also Ask — Irbesartan Supplier & Trade Network
Who are the top suppliers of Irbesartan from India?+
Which companies buy Irbesartan from Indian manufacturers?+
Where does Irbesartan exported from India go?+
What is the market share of the top Irbesartan supplier from India?+
What is the average shipment value for Irbesartan exports from India?+
Is Irbesartan manufactured in India and exported globally?+
Which country imports the most Irbesartan from India?+
Who are the buyers of Irbesartan in France?+
How concentrated is the Irbesartan supplier market in India?+
How do I find verified buyers for Irbesartan in specific countries?+
Irbesartan Trade Network — Key Takeaways
- 1MACLEODS PHARMACEUTICALS LTD is India's dominant Irbesartan exporter with a 30.4% market share and $32.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 123 suppliers collectively account for 62.6% of all tracked Irbesartan exports, with a combined trade value of $106.3M.
- 3United States is the largest destination market, absorbing 37.2% of India's Irbesartan exports ($39.5M). France (15.4%) and Australia (7.9%) follow.
- 4With 2.7K total shipments averaging $39.8K each, the Irbesartan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MACLEODS PHARMA USA INC, MACLEODS PHARMA USA INC, NEOETHICALS, S.A,, NUEVOS ETICOS NEOETHICALS, S.A. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 68 countries
Network value: $106.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Irbesartan.
- 2.Flow Mapping: 123 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,669 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 68 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,669 Verified Shipments
123 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists